Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study
Circulation · 30.09.2025 · 152 (13) · 913-923
DOI: 10.1161/circulationaha.124.073507 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Circulation, erschienen am 30.09.2025. Verfasst von Rémi Goupil und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hôpital de Sacré-Cœur de Montréal, CIUSSS-du-Nord-de-l'île-de-Montréal, Montreal, QC, Canada (R.G., F.M.). Hauptthemen laut MEDLINE: Hyperaldosteronism, Cardiovascular Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Primary aldosteronism (PA), an overt form of renin-independent aldosterone production, leads to a disproportionately high rate of major adverse cardiovascular events (MACEs). Mounting evidence suggests that milder forms of renin-independent aldosterone production (subclinical PA) are highly prevalent; however, the link between subclinical PA and MACE remains uncertain. METHODS: This prospective study included 2017 Canadian adults 40 to 69 years of age from the randomly sampled, population-based CARTaGENE cohort (Québec, Canada), in which aldosterone and renin concentrations at enrollment (2009–2010) were measured. Follow-up data were obtained via provincial health care administrative database linkage. MACE outcomes consisted of a composite of myocardial infarction, stroke, hospitalization for heart failure, and cardiovascular death. Multivariable linear and nonlinear Cox regression models measured the associations of concentrations of aldosterone, renin, and the aldosterone-to-renin ratio with MACE. Outcome-derived optimal thresholds for these markers were then determined. RESULTS: The mean (SD) age of participants was 56 (8) years, and 45% were women. Mean blood pressure was 129 (15)/76 (10) mm Hg, with hypertension being present in 27%. Over a median follow-up time of 10.8 years, 57 (3%) MACE outcomes occurred. Lower renin concentration (adjusted hazard ratio [aHR], 2.22 [95% CI, 1.02–4.76]) and higher aldosterone-to-renin ratio (aHR, 2.43 [95% CI, 1.15–5.12]) were associated with a higher risk for MACE, whereas no significant association was found with aldosterone concentration (aHR, 1.57 [95% CI, 0.42–5.90]). Renin concentration exhibited a nonlinear relationship with MACE risk. The outcome-derived optimal thresholds to discriminate a higher MACE risk were renin concentration ≤4.0 ng/L (aHR, 2.12 [95% CI, 1.21–3.72]) and aldosterone-to-renin ratio ≥70 pmol/L per ng/L (aHR, 2.03 [95% CI, 1.09–3.80]). All aforementioned associations were independent of blood pressure. CONCLUSIONS: Independent of blood pressure, the subclinical PA biochemical phenotype is associated with an increased risk of MACE. Future studies are necessary to determine whether early identification and targeted treatment of subclinical PA mitigates this risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hôpital de Sacré-Cœur de Montréal, CIUSSS-du-Nord-de-l'île-de-Montréal, Montreal, QC, Canada (R.G., F.M.).
- Departments of Medicine (L.-C.D., R.G., F.M., A.-C.N.-F.), Université de Montréal, Montreal, QC, Canada.
- Pharmacology and Physiology (R.G., A.M.), Université de Montréal, Montreal, QC, Canada.
- Department of Medicine, CHU de Québec-Université Laval, Quebec City, QC, Canada (M.A.).
- Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.V.).
- Community Health Sciences (A.A.L.), Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
ORCID-Profile: Rémi Goupil, Mohsen Agharazii, Anand Vaidya, Alexander A Leung, Gregory A Kline, Julie L V Shaw, Tim Ramsay, Annie-Claire Nadeau-Fredette, Manish M Sood, Gregory L Hundemer
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Goupil, R., Desbiens, L. C., Merabtine, A., Agharazii, M., Madore, F., Vaidya, A., Leung, A. A., Kline, G. A., Shaw, J. L. V., Ramsay, T., Nadeau-Fredette, A. C., Sood, M. M., & Hundemer, G. L. (2025). Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study. Circulation, 152(13), 913-923. https://doi.org/10.1161/circulationaha.124.073507
Vancouver
Goupil R, Desbiens LC, Merabtine A, Agharazii M, Madore F, Vaidya A, et al. Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study. Circulation. 2025;152(13):913-923. doi:10.1161/circulationaha.124.073507
BibTeX
@article{Goupil2025,
author = {Goupil, Rémi and Desbiens, Louis-Charles and Merabtine, Amel and Agharazii, Mohsen and Madore, François and Vaidya, Anand and Leung, Alexander A and Kline, Gregory A and Shaw, Julie L V and Ramsay, Tim and Nadeau-Fredette, Annie-Claire and Sood, Manish M and Hundemer, Gregory L},
title = {Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study},
journal = {Circulation},
year = {2025},
volume = {152},
number = {13},
pages = {913--923},
doi = {10.1161/circulationaha.124.073507}
}
EUVIMED